446 related articles for article (PubMed ID: 17292458)
1. Diethylstilbestrol (DES)-induced clear cell adenocarcinoma of the vagina metastasizing to the brain.
Lin LM; Sciubba DM; Gallia GL; Sosnowski J; Weingart JD
Gynecol Oncol; 2007 Apr; 105(1):273-6. PubMed ID: 17292458
[TBL] [Abstract][Full Text] [Related]
2. Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma.
Waggoner SE; Mittendorf R; Biney N; Anderson D; Herbst AL
Gynecol Oncol; 1994 Nov; 55(2):238-44. PubMed ID: 7959291
[TBL] [Abstract][Full Text] [Related]
3. Endobronchial clear cell adenocarcinoma occurring in a patient 15 years after treatment for DES-associated vaginal clear cell adenocarcinoma.
Hall WB; Detterbeck FC; Livasy CA; Fowler WC
Gynecol Oncol; 2004 Jun; 93(3):708-10. PubMed ID: 15196869
[TBL] [Abstract][Full Text] [Related]
4. Colposcopic and pathologic features in two cases of DES-related vaginal clear-cell adenocarcinoma.
Blythe JG; Michael H; Hodel KA
J Reprod Med; 1983 Feb; 28(2):137-46. PubMed ID: 6834354
[TBL] [Abstract][Full Text] [Related]
5. Primary non-clear-cell adenocarcinomas of the vagina in older DES-exposed women.
DeMars LR; Van Le L; Huang I; Fowler WC
Gynecol Oncol; 1995 Sep; 58(3):389-92. PubMed ID: 7672708
[TBL] [Abstract][Full Text] [Related]
6. [Vaginal and cervical cancer due to diethylstilbestrol (DES); end epidemic].
van Dijck JA; Doorduijn Y; Bulten JH; Verloop J; Massuger LF; Kiemeney BA
Ned Tijdschr Geneeskd; 2009; 153():A366. PubMed ID: 19857300
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstilbestrol exposure in utero.
Boyd J; Takahashi H; Waggoner SE; Jones LA; Hajek RA; Wharton JT; Liu FS; Fujino T; Barrett JC; McLachlan JA
Cancer; 1996 Feb; 77(3):507-13. PubMed ID: 8630958
[TBL] [Abstract][Full Text] [Related]
8. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
[TBL] [Abstract][Full Text] [Related]
9. Clear cell adenocarcinoma of the vagina in a young female, treated by combination chemotherapy (local and systemic chemotherapy), complicated with chromosomal abnormality.
Tanaka H; Tabata T; Yanase H; Nishiyama M; Yamawaki T; Taniguchi H; Toyoda N
Gynecol Oncol; 1994 Nov; 55(2):259-64. PubMed ID: 7959294
[TBL] [Abstract][Full Text] [Related]
10. [A case of vaginal adenocarcinoma after uterine exposure to diethylstilbestrol].
Schreiner WE; Bronz L; Wyss-Bernet M; Genton CY
Schweiz Med Wochenschr; 1985 Nov; 115(44):1555-61. PubMed ID: 3841230
[TBL] [Abstract][Full Text] [Related]
11. [DES syndrome].
Yaginuma T
Ryoikibetsu Shokogun Shirizu; 1993; (1):658-60. PubMed ID: 7757704
[No Abstract] [Full Text] [Related]
12. Development of DES-associated clear-cell carcinoma: the importance of regular screening.
Anderson B; Watring WG; Edinger DD; Small EC; Netland AT; Safaii H
Obstet Gynecol; 1979 Mar; 53(3):293-9. PubMed ID: 424100
[TBL] [Abstract][Full Text] [Related]
13. The long-term effects of in utero exposures--the DES story.
Goodman A; Schorge J; Greene MF
N Engl J Med; 2011 Jun; 364(22):2083-4. PubMed ID: 21506735
[No Abstract] [Full Text] [Related]
14. Diethylstilbestrol exposure and the risk of clear cell cervical and vaginal adenocarcinoma.
Edelman DA
Int J Fertil; 1989; 34(4):251-5. PubMed ID: 2570761
[TBL] [Abstract][Full Text] [Related]
15. DES: a continuing health concern.
Shaffer NG
Pa Med; 2000 Mar; 103(3):17. PubMed ID: 10765641
[No Abstract] [Full Text] [Related]
16. Development of clear cell adenocarcinoma in DES-exposed offspring under observation.
Kaufman RH; Korhonen MO; Strama T; Adam E; Kaplan A
Obstet Gynecol; 1982 Jun; 59(6 Suppl):68S-72S. PubMed ID: 7088431
[TBL] [Abstract][Full Text] [Related]
17. The current status of the DES-exposed population.
Herbst AL
Obstet Gynecol Annu; 1981; 10():267-78. PubMed ID: 7024873
[TBL] [Abstract][Full Text] [Related]
18. A case of vaginal clear cell adenocarcinoma complicated with congenital anomalies of the genitourinary tract and metanephric remnant without prenatal diethylstilbestrol exposure.
Uehara T; Onda T; Sasajima Y; Sawada M; Kasamatsu T
J Obstet Gynaecol Res; 2010 Jun; 36(3):681-5. PubMed ID: 20598057
[TBL] [Abstract][Full Text] [Related]
19. [Pulmonary metastases from a hormone-induced clear cell adenocarcinoma of the vagina].
Nesme P; Bayle JY; Pérol M; Mathevet P; Vitrey D; Guérin JC
Rev Mal Respir; 1993; 10(6):560-2. PubMed ID: 8122025
[TBL] [Abstract][Full Text] [Related]
20. Transition of benign vaginal adenosis to clear cell carcinoma.
Ghosh TK; Cera PJ
Obstet Gynecol; 1983 Jan; 61(1):126-30. PubMed ID: 6823342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
